Cell lines:
Tumors:
- HSC70 is localized to 11q23.3, a region deleted in 40% of sporadic breast and other cancers. Sequencing demonstrated mutation in the NH2-terminal ATPase domain of HSC70 in 2 of 15 sporadic breast carcinomas examined. In both cases, mutation was coincident with allelic imbalance, suggesting that HSC70 is a target of somatic mutation and deletion in a fraction of breast carcinomas. The mutations identified may affect the binding and hydrolysis of ATP and/or the binding of the two cofactors, p48 and
BAG-1 (Bakkenist C.J. et al., 1999).